Cargando…
Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity
Sequence-specific oligomers with predictable folding patterns, i.e., foldamers, provide new opportunities to mimic α-helical peptides and design inhibitors of protein-protein interactions. One major hurdle of this strategy is to retain the correct orientation of key side chains involved in protein s...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978421/ https://www.ncbi.nlm.nih.gov/pubmed/33741589 http://dx.doi.org/10.1126/sciadv.abd9153 |
_version_ | 1783667206131810304 |
---|---|
author | Mbianda, Johanne Bakail, May André, Christophe Moal, Gwenaëlle Perrin, Marie E. Pinna, Guillaume Guerois, Raphaël Becher, Francois Legrand, Pierre Traoré, Seydou Douat, Céline Guichard, Gilles Ochsenbein, Françoise |
author_facet | Mbianda, Johanne Bakail, May André, Christophe Moal, Gwenaëlle Perrin, Marie E. Pinna, Guillaume Guerois, Raphaël Becher, Francois Legrand, Pierre Traoré, Seydou Douat, Céline Guichard, Gilles Ochsenbein, Françoise |
author_sort | Mbianda, Johanne |
collection | PubMed |
description | Sequence-specific oligomers with predictable folding patterns, i.e., foldamers, provide new opportunities to mimic α-helical peptides and design inhibitors of protein-protein interactions. One major hurdle of this strategy is to retain the correct orientation of key side chains involved in protein surface recognition. Here, we show that the structural plasticity of a foldamer backbone may notably contribute to the required spatial adjustment for optimal interaction with the protein surface. By using oligoureas as α helix mimics, we designed a foldamer/peptide hybrid inhibitor of histone chaperone ASF1, a key regulator of chromatin dynamics. The crystal structure of its complex with ASF1 reveals a notable plasticity of the urea backbone, which adapts to the ASF1 surface to maintain the same binding interface. One additional benefit of generating ASF1 ligands with nonpeptide oligourea segments is the resistance to proteolysis in human plasma, which was highly improved compared to the cognate α-helical peptide. |
format | Online Article Text |
id | pubmed-7978421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-79784212021-03-31 Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity Mbianda, Johanne Bakail, May André, Christophe Moal, Gwenaëlle Perrin, Marie E. Pinna, Guillaume Guerois, Raphaël Becher, Francois Legrand, Pierre Traoré, Seydou Douat, Céline Guichard, Gilles Ochsenbein, Françoise Sci Adv Research Articles Sequence-specific oligomers with predictable folding patterns, i.e., foldamers, provide new opportunities to mimic α-helical peptides and design inhibitors of protein-protein interactions. One major hurdle of this strategy is to retain the correct orientation of key side chains involved in protein surface recognition. Here, we show that the structural plasticity of a foldamer backbone may notably contribute to the required spatial adjustment for optimal interaction with the protein surface. By using oligoureas as α helix mimics, we designed a foldamer/peptide hybrid inhibitor of histone chaperone ASF1, a key regulator of chromatin dynamics. The crystal structure of its complex with ASF1 reveals a notable plasticity of the urea backbone, which adapts to the ASF1 surface to maintain the same binding interface. One additional benefit of generating ASF1 ligands with nonpeptide oligourea segments is the resistance to proteolysis in human plasma, which was highly improved compared to the cognate α-helical peptide. American Association for the Advancement of Science 2021-03-19 /pmc/articles/PMC7978421/ /pubmed/33741589 http://dx.doi.org/10.1126/sciadv.abd9153 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Research Articles Mbianda, Johanne Bakail, May André, Christophe Moal, Gwenaëlle Perrin, Marie E. Pinna, Guillaume Guerois, Raphaël Becher, Francois Legrand, Pierre Traoré, Seydou Douat, Céline Guichard, Gilles Ochsenbein, Françoise Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity |
title | Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity |
title_full | Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity |
title_fullStr | Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity |
title_full_unstemmed | Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity |
title_short | Optimal anchoring of a foldamer inhibitor of ASF1 histone chaperone through backbone plasticity |
title_sort | optimal anchoring of a foldamer inhibitor of asf1 histone chaperone through backbone plasticity |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978421/ https://www.ncbi.nlm.nih.gov/pubmed/33741589 http://dx.doi.org/10.1126/sciadv.abd9153 |
work_keys_str_mv | AT mbiandajohanne optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT bakailmay optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT andrechristophe optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT moalgwenaelle optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT perrinmariee optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT pinnaguillaume optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT gueroisraphael optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT becherfrancois optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT legrandpierre optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT traoreseydou optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT douatceline optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT guichardgilles optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity AT ochsenbeinfrancoise optimalanchoringofafoldamerinhibitorofasf1histonechaperonethroughbackboneplasticity |